Researchers report that early treatment of type 2 diabetes with tirzepatide leads to greater improvements over 2 years in blood sugar, body weight, and waist size than treatment… read more.
Researchers report that vitamin D deficiency is associated with more moderate to severe pain after breast cancer surgery. The findings were published online on May 19, 2026 in… read more.
Treatment with CGRP inhibitors, a class of drugs used to prevent migraine, appears to be associated with a reduced risk of glaucoma, researchers reported on May 6, 2026… read more.
Researchers report that weight-loss surgery improves outcomes for patients with obesity and chronic kidney disease by significantly reducing the risk of kidney failure, major cardiovascular events and death…. read more.
A new meta-analysis of relevant clinical studies suggests that GLP 1 weight-loss drugs provide protection against heart attacks, strokes and premature death for up to 2.7 years. The… read more.
Researchers report that GMRx2, a single daily pill combining telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg, lowers the risk of recurrent stroke by 39%. The findings from the… read more.
People who have experienced childhood sexual abuse have twice the odds of receiving a cancer diagnosis at age 65 or older compared to others who have not experienced… read more.
Asundexian, an investigational anti clotting medication, appears to lower the risk of stroke without increasing bleeding in patients who have had a recent stroke or transient ischemic attack… read more.
The antidepressant duloxetine does not appear to prevent chemotherapy-associated nerve damage in colorectal cancer. This finding appeared in the JCO Oncology Advances on March 25, 2026 followed by… read more.
There appears to be no association between hormonal contraception and the prevalence of idiopathic intracranial hypertension, researchers reported on March 25, 2026 in Neurology, the medical journal of… read more.
Researchers report that the antidepressant fluvoxamine has significantly reduced long COVID–related fatigue, and that the diabetes drug metformin has no such benefit. “Patients taking fluvoxamine reported steadily improving… read more.
Researchers report that people with type 1 diabetes are nearly three times as likely to develop dementia compared to those without type 1 diabetes. The findings appeared in… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
